HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arthur Kavanaugh Selected Research

Arthur Kavanaugh Research Topics

Disease

102Psoriatic Arthritis
08/2022 - 04/2005
95Rheumatoid Arthritis
01/2022 - 02/2002
40Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 04/2005
23Arthritis (Polyarthritis)
08/2022 - 04/2005
21Pain (Aches)
01/2020 - 02/2004
17Infections
01/2022 - 05/2004
17Necrosis
01/2020 - 10/2003
16Ankylosing Spondylitis
08/2022 - 07/2006
16Inflammation (Inflammations)
01/2022 - 07/2008
13Fatigue
01/2021 - 02/2004
9Autoimmune Diseases (Autoimmune Disease)
01/2018 - 10/2005
8Neoplasms (Cancer)
01/2022 - 07/2008
7Rheumatic Diseases (Rheumatism)
01/2018 - 02/2006
6Joint Diseases (Joint Disease)
01/2021 - 09/2013
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 10/2002
6Disease Progression
09/2019 - 03/2006
5Tuberculosis (Tuberculoses)
01/2022 - 05/2004
5Chronic Disease (Chronic Diseases)
01/2021 - 12/2015
4Spondylitis
04/2022 - 12/2008
4Gout
01/2017 - 03/2006
3Opportunistic Infections (Opportunistic Infection)
01/2022 - 03/2015
3Respiratory Tract Infections (Respiratory Tract Infection)
08/2020 - 09/2015
3Nasopharyngitis
08/2020 - 09/2015
3Crohn Disease (Crohn's Disease)
01/2020 - 11/2007
3Synovitis
01/2019 - 02/2011
2Headache (Headaches)
08/2020 - 10/2016
2Musculoskeletal Diseases (Musculoskeletal Disease)
01/2020 - 01/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2018
2Candidiasis (Moniliasis)
01/2020 - 01/2018
2Hypertension (High Blood Pressure)
01/2019 - 05/2016
2Lymphoma (Lymphomas)
11/2017 - 03/2015
2Heart Failure
01/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

43Biological ProductsIBA
01/2022 - 09/2003
30Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 10/2002
25Adalimumab (Humira)FDA Link
11/2020 - 07/2006
22golimumabFDA Link
01/2022 - 04/2009
20Tumor Necrosis Factor InhibitorsIBA
08/2022 - 05/2004
18Antirheumatic Agents (DMARD)IBA
01/2022 - 10/2003
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2020 - 06/2002
17C-Reactive ProteinIBA
08/2022 - 02/2011
13Ustekinumab (CNTO 1275)FDA Link
01/2020 - 02/2009
12ametantrone (HAQ)IBA
10/2020 - 02/2004
11apremilastIBA
01/2022 - 01/2014
10tocilizumab (atlizumab)FDA Link
05/2020 - 01/2007
10Infliximab (Remicade)FDA Link
08/2013 - 06/2002
9secukinumabIBA
01/2022 - 09/2015
8tofacitinibIBA
01/2022 - 01/2014
8Monoclonal AntibodiesIBA
01/2020 - 02/2009
7Interleukin-17 (Interleukin 17)IBA
01/2020 - 02/2014
7Rituximab (Mabthera)FDA Link
01/2016 - 09/2003
6Pharmaceutical PreparationsIBA
08/2022 - 01/2003
6Etanercept (Enbrel)FDA Link
01/2022 - 07/2006
6LipidsIBA
01/2022 - 10/2002
6Certolizumab PegolFDA Link
01/2020 - 01/2009
6Interleukin-6 (Interleukin 6)IBA
10/2016 - 01/2003
5Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2003
5Interleukin-12 (IL 12)IBA
01/2020 - 02/2009
5CytokinesIBA
09/2015 - 02/2002
5Syk KinaseIBA
12/2014 - 11/2008
4AntibodiesIBA
08/2022 - 03/2014
4AntigensIBA
01/2020 - 03/2003
4fostamatinibIBA
12/2014 - 02/2011
4GlucocorticoidsIBA
10/2014 - 10/2003
3GLPG0634IBA
01/2022 - 01/2018
3Janus Kinase InhibitorsIBA
01/2022 - 12/2018
3OxylipinsIBA
01/2022 - 01/2021
3Rheumatoid FactorIBA
12/2021 - 05/2007
3ixekizumabIBA
01/2021 - 07/2019
3Prostaglandins AIBA
01/2019 - 09/2009
3Phosphodiesterase 4 InhibitorsIBA
01/2018 - 06/2014
3AutoantibodiesIBA
01/2018 - 02/2006
3Uric Acid (Urate)IBA
01/2016 - 03/2006
3InterleukinsIBA
06/2014 - 02/2009
3Proteins (Proteins, Gene)FDA Link
01/2013 - 01/2004
3Immunoglobulins (Immunoglobulin)IBA
10/2010 - 12/2007
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
03/2006 - 09/2003
2bimekizumabIBA
07/2022 - 01/2020
2HLA-B27 Antigen (HLA B27 Antigen)IBA
05/2022 - 01/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 06/2011
2omega-Chloroacetophenone (Mace)IBA
01/2022 - 03/2021
2Anti-Citrullinated Protein AntibodiesIBA
12/2021 - 01/2008
2cyclic citrullinated peptideIBA
12/2021 - 01/2008
2Leflunomide (Arava)FDA LinkGeneric
06/2020 - 08/2004
2Antiphospholipid AntibodiesIBA
01/2020 - 01/2020
2Interleukin-23 (Interleukin 23)IBA
12/2019 - 06/2014
2amsonic acid (DAS)IBA
05/2019 - 01/2019
2Biosimilar PharmaceuticalsIBA
01/2019 - 01/2018
2GP2015IBA
01/2019 - 01/2018
2SteroidsIBA
01/2018 - 02/2011
2EpitopesIBA
01/2018 - 11/2009
2PegloticaseFDA Link
01/2017 - 03/2014
2Lipoproteins (Lipoprotein)IBA
10/2016 - 10/2002
2VaccinesIBA
01/2016 - 01/2016

Therapy/Procedure

69Therapeutics
04/2022 - 02/2002
8Biological Therapy
01/2018 - 07/2007
3Subcutaneous Injections
01/2020 - 04/2009
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2020 - 01/2020
2Contraception (Birth Control)
01/2020 - 01/2020
2Excimer Lasers
09/2019 - 01/2012
2Aftercare (After-Treatment)
11/2018 - 10/2016